Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410047 | SCV000486794 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-08-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000410047 | SCV001590027 | pathogenic | Ataxia-telangiectasia syndrome | 2021-10-08 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 371256). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe1201Leufs*6) in the ATM gene. It is expected to result in an absent or disrupted protein product. |
Myriad Genetics, |
RCV004022146 | SCV004930500 | pathogenic | Familial cancer of breast | 2024-01-22 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |